Optimizing the Clinical Application of CAR T-Cell Therapy: Best Practices for the Community Setting

Review key strategies for integrating CAR T-cell therapy into community-based management of hematologic malignancies with a CME/CE/CPE-certified on-demand Webcast, FAQ module, and downloadable slides from a live expert-led series.
person default
Michael R. Bishop, MD
Jae H. Park, MD

Downloadable Slideset

Download these slides from our live meeting series to review key strategies for integrating CAR T-cell therapy into community-based management of patients with hematologic malignancies.

person default Michael R. Bishop, MD Jae H. Park, MD Released: September 6, 2019
Provided by Postgraduate Institute for Medicine
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com

Supported by educational grants from
Celgene Corporation
Kite, A Gilead Company

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?